142 related articles for article (PubMed ID: 33677721)
1. Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.
Dzinovic I; Serranová T; Prouteau C; Colin E; Ziegler A; Winkelmann J; Jech R; Zech M
Neurogenetics; 2021 May; 22(2):137-141. PubMed ID: 33677721
[TBL] [Abstract][Full Text] [Related]
2. Intragenic CAMTA1 rearrangements cause non-progressive congenital ataxia with or without intellectual disability.
Thevenon J; Lopez E; Keren B; Heron D; Mignot C; Altuzarra C; Béri-Dexheimer M; Bonnet C; Magnin E; Burglen L; Minot D; Vigneron J; Morle S; Anheim M; Charles P; Brice A; Gallagher L; Amiel J; Haffen E; Mach C; Depienne C; Doummar D; Bonnet M; Duplomb L; Carmignac V; Callier P; Marle N; Mosca-Boidron AL; Roze V; Aral B; Razavi F; Jonveaux P; Faivre L; Thauvin-Robinet C
J Med Genet; 2012 Jun; 49(6):400-8. PubMed ID: 22693284
[TBL] [Abstract][Full Text] [Related]
3. De novo variants in CAMTA1 cause a syndrome variably associated with spasticity, ataxia, and intellectual disability.
Wijnen IGM; Veenstra-Knol HE; Vansenne F; Gerkes EH; de Koning T; Vos YJ; Tijssen MAJ; Sival D; Darin N; Vanhoutte EK; Oosterloo M; Pennings M; van de Warrenburg BP; Kamsteeg EJ
Eur J Hum Genet; 2020 Jun; 28(6):763-769. PubMed ID: 32157189
[TBL] [Abstract][Full Text] [Related]
4. Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes.
Shinawi M; Coorg R; Shimony JS; Grange DK; Al-Kateb H
Clin Genet; 2015 May; 87(5):478-82. PubMed ID: 24738973
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological and neuroimaging phenotype induced by a CAMTA1 mutation.
Magnin E; Blagosklonov O; Sylvestre G; Minot D; Thevenon J; Faivre L; Boulahdour H; Thauvin-Robinet C; Rumbach L
Brain Dev; 2014 Sep; 36(8):711-5. PubMed ID: 24145135
[TBL] [Abstract][Full Text] [Related]
6. Expanding the molecular spectrum and the neurological phenotype related to CAMTA1 variants.
Jacobs EZ; Brown K; Byler MC; D'haenens E; Dheedene A; Henderson LB; Humberson JB; van Jaarsveld RH; Kanani F; Lebel RR; Millan F; Oegema R; Oostra A; Parker MJ; Rhodes L; Saenz M; Seaver LH; Si Y; Vanlander A; Vergult S; Callewaert B
Clin Genet; 2021 Feb; 99(2):259-268. PubMed ID: 33131045
[TBL] [Abstract][Full Text] [Related]
7. CAMTA1-related disorder: Phenotypic and molecular characterization of 26 new individuals and literature review.
Al-Kateb H; Au PYB; Berland S; Cogne B; Demurger F; Fluss J; Isidor B; Frank LM; Varvagiannis K; Koolen DA; McDonald M; Montgomery S; Moortgat S; Deprez M; Karadurmus D; Paulsen J; Reis A; Rieger M; Vasileiou G; Willing M; Shinawi M
Clin Genet; 2024 Mar; 105(3):294-301. PubMed ID: 38044714
[TBL] [Abstract][Full Text] [Related]
8. Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia.
Khan K; Zech M; Morgan AT; Amor DJ; Skorvanek M; Khan TN; Hildebrand MS; Jackson VE; Scerri TS; Coleman M; Rigbye KA; Scheffer IE; Bahlo M; Wagner M; Lam DD; Berutti R; Havránková P; Fečíková A; Strom TM; Han V; Dosekova P; Gdovinova Z; Laccone F; Jameel M; Mooney MR; Baig SM; Jech R; Davis EE; Katsanis N; Winkelmann J
Genet Med; 2019 Nov; 21(11):2532-2542. PubMed ID: 31036918
[TBL] [Abstract][Full Text] [Related]
9. A unique de novo gain-of-function variant in
Zech M; Lam DD; Weber S; Berutti R; Poláková K; Havránková P; Fečíková A; Strom TM; Růžička E; Jech R; Winkelmann J
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30262571
[TBL] [Abstract][Full Text] [Related]
10. CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes.
Sorrentino U; Boesch S; Doummar D; Ravelli C; Serranova T; Indelicato E; Winkelmann J; Burglen L; Jech R; Zech M
J Neurol; 2024 May; 271(5):2859-2865. PubMed ID: 38441608
[TBL] [Abstract][Full Text] [Related]
11. The role of Calmodulin Binding Transcription Activator 1 (CAMTA1) gene and its putative genetic partners in the human nervous system.
Alves G; Ornellas MH; Liehr T
Psychogeriatrics; 2022 Nov; 22(6):869-878. PubMed ID: 35949142
[TBL] [Abstract][Full Text] [Related]
12. Recessive null-allele variants in MAG associated with spastic ataxia, nystagmus, neuropathy, and dystonia.
Zech M; Brunet T; Škorvánek M; Blaschek A; Vill K; Hanker B; Hüning I; Haň V; Došekova P; Gdovinová Z; Alhaddad B; Berutti R; Strom TM; Růžička E; Kamsteeg EJ; van der Smagt JJ; Wagner M; Jech R; Winkelmann J
Parkinsonism Relat Disord; 2020 Aug; 77():70-75. PubMed ID: 32629324
[TBL] [Abstract][Full Text] [Related]
13. Hereditary Myoclonus Dystonia: A Novel
Coughlin DG; Bardakjian TM; Spindler M; Deik A
Tremor Other Hyperkinet Mov (N Y); 2018; 8():547. PubMed ID: 29607243
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation of the epsilon-sarcoglycan gene in a Chinese family with myoclonus-dystonia syndrome.
Chen XP; Zhang YW; Zhang SS; Chen Q; Burgunder JM; Wu SH; Yang Y; Luo ZM; Shang HF
Mov Disord; 2008 Jul; 23(10):1472-5. PubMed ID: 18581468
[TBL] [Abstract][Full Text] [Related]
15. Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation.
Maréchal L; Raux G; Dumanchin C; Lefebvre G; Deslandre E; Girard C; Campion D; Parain D; Frebourg T; Hannequin D
Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):114-7. PubMed ID: 12707948
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the epsilon-sarcoglycan gene found to be uncommon in seven myoclonus-dystonia families.
Han F; Lang AE; Racacho L; Bulman DE; Grimes DA
Neurology; 2003 Jul; 61(2):244-6. PubMed ID: 12874409
[TBL] [Abstract][Full Text] [Related]
17. ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures.
Poggio E; Barazzuol L; Salmaso A; Milani C; Deligiannopoulou A; Cazorla ÁG; Jang SS; Juliá-Palacios N; Keren B; Kopajtich R; Lynch SA; Mignot C; Moorwood C; Neuhofer C; Nigro V; Oostra A; Prokisch H; Saillour V; Schuermans N; Torella A; Verloo P; Yazbeck E; Zollino M; Jech R; Winkelmann J; Necpal J; Calì T; Brini M; Zech M
Genet Med; 2023 Dec; 25(12):100971. PubMed ID: 37675773
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype correlation: Inheritance and variant-type infer pathogenicity in IQSEC2 gene.
Barrie ES; Cottrell CE; Gastier-Foster J; Hickey SE; Patel AD; Santoro SL; Alfaro MP
Eur J Med Genet; 2020 Mar; 63(3):103735. PubMed ID: 31415821
[TBL] [Abstract][Full Text] [Related]
19. Frequency and phenotypic spectrum of KMT2B dystonia in childhood: A single-center cohort study.
Carecchio M; Invernizzi F; Gonzàlez-Latapi P; Panteghini C; Zorzi G; Romito L; Leuzzi V; Galosi S; Reale C; Zibordi F; Joseph AP; Topf M; Piano C; Bentivoglio AR; Girotti F; Morana P; Morana B; Kurian MA; Garavaglia B; Mencacci NE; Lubbe SJ; Nardocci N
Mov Disord; 2019 Oct; 34(10):1516-1527. PubMed ID: 31216378
[TBL] [Abstract][Full Text] [Related]
20. Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome.
Kuechler A; Zink AM; Wieland T; Lüdecke HJ; Cremer K; Salviati L; Magini P; Najafi K; Zweier C; Czeschik JC; Aretz S; Endele S; Tamburrino F; Pinato C; Clementi M; Gundlach J; Maylahn C; Mazzanti L; Wohlleber E; Schwarzmayr T; Kariminejad R; Schlessinger A; Wieczorek D; Strom TM; Novarino G; Engels H
Eur J Hum Genet; 2015 Jun; 23(6):753-60. PubMed ID: 25138099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
